Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 23, 2017
ChromaDex has signed a definitive agreement to sell its analytical testing services business to LabCorp.
read more
Chemic Laboratories Inc. and ASI today announced
establishment of a formal three year Joint Cooperation Agreement that will enable the two firms
to collaborate on a variety of Pharmaceutical and Biopharmaceutical client interests, primarily in
the...
read more
Friday, November 20, 2020
PathoQuest and Charles River has established a U.S. subsidiary, PathoQuest and will construct a next generation sequencing-based testing laboratory at Charles River’s site in Wayne, PA.
read more
Thursday, October 18, 2012
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has been selected by AstraZeneca (NYSE: AZN) as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and ...
read more
Wednesday, April 16, 2014
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of the CRO services division of Galapagos NV (Euronext: GLPG), which includes both Argenta and BioFocus. The ...
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new gene and cell therapies.
read more
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the...
read more
Catalent Pharma Solutions, a leading supplier of inhalation drug development, delivery and supply capabilities, today announced that it has entered into a contract with Biota Pharmaceuticals, Inc. (“Biota”), to develop and provide filling and ...
read more
Friday, December 12, 2014
Capillary Film Technology Limited (CFT), a UK based technology and product development company for life sciences and clinical diagnostics, today announced it has received £1 million in funding through a Phase 2 Small Business Research Initiative for ...
read more
Tuesday, September 17, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing ...
read more
Tuesday, February 18, 2014
Camargo Pharmaceutical Services’ Ready 4 Action
proprietary feasibility assessment enables drug developers — generic companies in particular
— to identify viable products to bring to market. Camargo will be exhibiting at the Generic
Pharmaceutical...
read more
The U.S. regulatory landscape has changed dramatically in 10 years. In 2003, the FDA finally resolved legal hurdles to the 505(b)(2) approval pathway, making it a practical alternative route for drug development. The same year, Ken Phelps and Ruth ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
Wednesday, March 06, 2013
Sigma-Aldrich® Corporation today announced that BioReliance® (http://www.bioreliance.com), the biologics and early development services business under SAFC® (www.safcglobal.com), has signed an agreement to acquire the colonies required for the Big ...
read more
Tuesday, February 18, 2014
BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced the opening of a new Biosimilar Centre of Excellence in Glasgow. The new facility ...
read more